Scribd
Upload
23 views4 pages

NGS in Pediatrics: Exam Notes

Next Generation Sequencing (NGS) is a high-throughput method for sequencing millions of DNA fragments, with applications in pediatrics including rare genetic disorders, neurodevelopmental disorders, oncology, and more. It offers advantages such as high throughput and the ability to detect multiple mutation types, but has limitations like ethical concerns and expensive costs. Genetic counseling is essential before and after testing due to potential incidental findings.

Uploaded by

sudhanshkumar9
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
23 views4 pages

NGS in Pediatrics: Exam Notes

Next Generation Sequencing (NGS) is a high-throughput method for sequencing millions of DNA fragments, with applications in pediatrics including rare genetic disorders, neurodevelopmental disorders, oncology, and more. It offers advantages such as high throughput and the ability to detect multiple mutation types, but has limitations like ethical concerns and expensive costs. Genetic counseling is essential before and after testing due to potential incidental findings.

Uploaded by

sudhanshkumar9
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Here is a detailed exam-oriented note on Next Generation Sequencing (NGS) and its

Applications in Pediatrics based on Nelson Textbook of Pediatrics, 22nd Edition:

📘 Next Generation Sequencing (NGS) - Detailed Notes (Nelson 22/e)


🔬 DEFINITION:

Next Generation Sequencing (NGS), also known as massively parallel sequencing, is a


high-throughput method that enables simultaneous sequencing of millions of DNA
fragments, allowing comprehensive analysis of genetic material.

🧬 TYPES OF NGS TESTS:


Test Scope Application

Selected genes (e.g., epilepsy, High yield in well-defined


Targeted Gene Panels
cardiomyopathy) clinical phenotypes

Whole Exome ~1–2% of genome (all coding Identifies mutations in protein-


Sequencing (WES) regions) coding genes

Broadest view, detects


Whole Genome 100% of DNA (coding + non-
structural and regulatory
Sequencing (WGS) coding)
variants

🧠 PRINCIPLE:

1. DNA is fragmented.
2. Fragments are ligated with adapters.
3. Amplification of library (PCR).
4. Sequencing using parallel processing.
5. Data alignment to a reference genome.
6. Variant identification (SNPs, INDELs, CNVs).

📊 ADVANTAGES:

• High throughput and fast.


• Detects multiple mutation types (point mutations, small insertions/deletions,
copy number variants).
• Requires small amounts of DNA.
• Can detect mosaicism and de novo mutations.

🚨 LIMITATIONS:

• Incidental/secondary findings (ethical concerns).


• May not detect triplet repeat disorders, methylation abnormalities, or large
structural variants well.
• Data interpretation requires expert bioinformatics.
• Expensive and not always clinically actionable.

👶 APPLICATIONS IN PEDIATRICS:
1. Rare Genetic Disorders:

• Diagnostic yield: 30–50% in children with neurodevelopmental delay, multiple


congenital anomalies.
• Example: Congenital hearing loss, intellectual disability, dysmorphic syndromes.

2. Neurodevelopmental Disorders:

• Autism Spectrum Disorders (ASD), epilepsy, cerebral palsy of unclear etiology.

3. Oncology:

• Detects actionable mutations in pediatric cancers (e.g., BCR-ABL, ALK, NTRK).


• Guides targeted therapy and risk stratification.

4. Immunodeficiencies:

• Primary immunodeficiencies (e.g., SCID variants, CGD).


• Uncovers new gene defects (e.g., DOCK8, RAG1).

5. Metabolic Disorders:

• Identifies mutations in inborn errors of metabolism (IEMs).


• Used when biochemical tests are inconclusive.

6. Cardiogenetic Disorders:

• Familial cardiomyopathies, arrhythmias (e.g., Long QT, Brugada syndrome).


7. Prenatal and Neonatal Diagnosis:

• Rapid WES for critically ill neonates in NICU.


• Identifies cause of unexplained seizures, hypotonia, metabolic acidosis.

8. Pharmacogenomics:

• Prediction of drug toxicity and dosing (e.g., TPMT for thiopurines, CYP2C19 for
antiepileptics).

⚖️ ETHICAL & COUNSELING ISSUES:

• Need for genetic counseling before and after testing.


• Managing incidental findings (e.g., BRCA mutations).
• Informed consent crucial (especially in WES/WGS).

🩺 CLINICAL CASE EXAMPLES (from Nelson):

• A child with early-onset epileptic encephalopathy diagnosed via NGS panel


showing SCN1A mutation (Dravet syndrome).
• An infant with severe combined immunodeficiency (SCID) diagnosed using
WES.
• Child with multiple congenital anomalies diagnosed with Kabuki syndrome
(KMT2D mutation) via WES.

📌 KEY POINTS FOR VIVA / THEORY:

• NGS = "Parallel sequencing of DNA fragments at high speed and scale."


• WES focuses on exons; WGS includes introns, promoters.
• Used in undiagnosed syndromic children.
• Must be interpreted in the clinical context.
• Always combine with genetic counseling.

📚 Nelson Reference:

• Nelson Textbook of Pediatrics, 22nd edition


• Refer: Chapter 74. Genetic Evaluation and Counseling
(Also check relevant disease-specific chapters with molecular diagnosis
sections.)

Let me know if you’d like this in handwritten style or as a printable PDF.

Common questions

Powered by AI

NGS offers high throughput and rapid sequencing, detecting diverse mutation types such as point mutations, small insertions/deletions, and copy number variants, requiring only small amounts of DNA, and identifying mosaicism and de novo mutations . However, limitations include the ethical concerns surrounding incidental findings, challenges in detecting certain genetic abnormalities like triplet repeat disorders and large structural variants, the need for expert bioinformatics for data interpretation, and significant costs without guaranteed clinical actionability .

In pediatric oncology, NGS is utilized to detect actionable mutations within pediatric cancers, like BCR-ABL, ALK, and NTRK, aiding in targeted therapy directions and risk stratification for patients . This capability allows clinicians to determine personalized treatment plans based on a tumor's genetic profile, enhancing the precision medicine approach and potentially improving treatment outcomes .

In cases of metabolic disorders where biochemical tests provide inconclusive results, NGS can identify mutations involved in inborn errors of metabolism (IEMs). By sequencing relevant genes or panels, it provides genetic confirmation or exclusion of suspected metabolic disorders, thus aiding in precise diagnostic clarification and informing appropriate treatment choices .

WGS provides a comprehensive analysis by sequencing 100% of the genome, including both coding and non-coding regions, allowing detection of structural and regulatory variants . In contrast, WES focuses only on the coding regions, comprising roughly 1–2% of the genome, and is primarily used to identify mutations in protein-coding genes . WGS might be preferable for a broad view of genetic information or when non-coding regions are of interest, whereas WES suits cases with known gene symptoms or when resources are limited as it is generally less expensive .

Combining NGS results with genetic counseling is vital as it helps parents and patients understand the implications of genetic findings, assess potential risks, and navigate decisions around further testing or interventions . Counseling provides the framework to process information concerning complex conditions, manage incidental findings ethically, and ensure families are informed and supported through the diagnostic journey, an essential component in pediatric care .

NGS is instrumental in diagnosing pediatric neurodevelopmental disorders by providing a diagnostic yield of 30-50% in children with conditions such as neurodevelopmental delay and multiple congenital anomalies . It is used for conditions like Autism Spectrum Disorders (ASD), epilepsy, and cerebral palsy when the etiology is unclear, enabling the identification of specific genetic mutations that may influence treatment and management strategies .

Pharmacogenomics, as applied through NGS, can enhance pediatric care by predicting drug toxicity and optimal dosing, tailored to the genetic makeup of individual patients . For example, it aids in identifying variations affecting drug metabolism pathways, such as TPMT for thiopurines and CYP2C19 for antiepileptics, leading to personalized medication plans that minimize adverse effects and improve therapeutic outcomes .

Targeted gene panels focus on pre-selected genes associated with specific conditions, such as epilepsy or cardiomyopathy, providing high diagnostic yield in well-characterized clinical phenotypes . In contrast, WES covers all coding regions (~1-2% of the genome), and WGS sequences the entire genome, providing broader detection scopes including both known and novel variants . Therefore, targeted panels are efficient for specific and well-defined conditions, whereas WES and WGS are suitable for broader, unexplained clinical contexts or novel variant detection .

Genetic counseling for NGS tests must address the management of incidental findings, such as unexpected mutations that could have significant implications, like BRCA mutations . Counselors need to ensure informed consent is obtained, clarifying potential outcomes and their implications, especially in expansive tests like WES and WGS . The counseling process should aid patients in understanding and weighing the benefits and risks of knowing genetic data, fostering informed decisions about participating in NGS testing .

Identifying structural and regulatory variants through WGS is significant as these variants often play crucial roles in the pathogenesis of diseases, particularly those not associated with coding regions . This comprehensive insight allows clinicians to understand genetic factors of diseases more broadly, impacting the diagnosis, prognosis, and potential therapeutic strategies by revealing complex genetic contributions beyond the scope of WES .

You might also like